Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion

por Chen, An-guo, Chen, Dong-sheng, Li, Si, Zhao, Le-le, Xiao, Ming-zhe
Publicado 2022

NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer

por Gong, Xiao-yang, Chen, Hai-bin, Zhang, Li-qing, Chen, Dong-sheng, Li, Wang, Chen, Dong-hui, Xu, Jin, Zhou, Han, Zhao, Le-le, Song, Yun-jie, Xiao, Ming-zhe, Deng, Wang-long, Qi, Chuang, Wang, Xue-rong, Chen, Xi
Publicado 2022